Advertisement

Here Are the Most Compelling Buys of the COVID Vaccine Stocks

Investors have multiple options when looking for companies in the coronavirus vaccine market. In this video from Motley Fool Live, recorded on Jan. 4, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss two companies, Johnson & Johnson (NYSE: JNJ) and Novavax (NASDAQ: NVAX), which offer distinct opportunities for different types of investors. Corinne Cardina: So as you survey the horizon of all the different companies involved, including the ones that do already have vaccines being administered, are any of these stocks particularly compelling buys today?